Sensex down 15
The
BSE Sensex opened at 5,886 points - touched a high of
5,897 before going to an intraday low of 5,781, to finally
close at 5,822 - down by 15 points. At the National Stock
Exchange (NSE), the 50-share Nifty index was down marginally
by 0.29 per cent.
BSE
Gainers
Infosys Technologies, Cipla, Gujarat Ambuja Cements, State
Bank of India, Ranbaxy Laboratories, HDFC, Wipro, Bharti
TeleVentures, Matrix Labs, HCL Technologies, Polaris Labs,
Hughes Software, E-Serve International, Mastek, Corporation
Bank
BSE Losers
ICICI Bank, HLL, L&T, Tata Motors, Tata Steel, HPCL,
Satyam Computers, HDFC Bank, Grasim Industries, Bajaj
Auto, Reliance Energy, Dr Reddy's Laboratories, BHEL,
Hero Honda, ACC, MTNL, Tata Power, Zee Telefilms
BSE Counters
Infosys Technologies was up about Rs 140 or 2.7 per cent
at Rs 5,312
Voltas closed today at Rs 136.85, gaining 18.90 per cent
MTNL was down 4.49 per cent at Rs 133.90
Pantaloon Retail gained 5.04 per cent at Rs 303.45
State Bank Of India closed 2.08 per cent higher by Rs
12.80, at Rs 627.40
Back
to News Review index page
NSE
warning on TV Today shares
Mumbai: The purchase of TV Today shares by FIIs/NRIs
in the secondary market has come to the notice of the
National Stock Exchange, where the shares of the company
are listed. These purchases are over and above the mandated
26 per cent purchase allowed for such entities, and seem
to have been done in the secondary market by way of circumventing
the regulation.
In a notice to its members the NSE has said that they
should inform their clients to disinvest the shares of
TV Today purchased by them.
Back
to News Review index page
Bonus and stock split for Infosys
Bangalore: The board of Infosys Technologies will
meet on April 13 to consider the issue of bonus shares
and stock split, the company has said in a notice to the
Bombay Stock Exchange (BSE). Also, the company will also
announce its fourth quarter and annual results for the
fiscal ending March 31, on April 13.
Back
to News Review index page
OCBs
permitted to buy equity in Orchid
Chennai: The Union Government has given permission
to two overseas corporate bodies, Medrox and Harpline,
to buy the equity shares of Orchid Chemicals & Pharmaceuticals
in the open market. The entities already have an equity
stake in the company.
The investment laws for EOUs dictate that foreign entities
need the government's permission to buy equity. The law
does not apply to foreign institutional investors and
non-resident Indians. Orchid Chemicals is an export-oriented
unit that manufactures largely antibiotics. The foreign
shareholding in Orchid Chemicals as of December 31, 2003
was 47.03 per cent.
Back
to News Review index page
SEBI: Disclosure document mandatory
for ESOP
Mumbai: According to the Securities and Exchange
Board of India (SEBI) employees who avail of the stock
option scheme will compulsorily have a disclosure document
provided to them. This requirement will be mandatory for
all options granted after June 30, 2003. This will include
a declaration by the company about the method of option
valuation it is going to use for accounting employee stock
options scheme (ESOP).
Further, in all initial public offers after June 30, 2003,
shares arising out of the option scheme, shall be immediately
listed provided that a statement in the prescribed format
is filed with the stock exchanges and an in-principle
approval is obtained before the exercise. The report also
clarified that in order to conform to the code of conduct
on insider trading, employees are required to hold their
investments in securities for a minimum period of 30 days
from the date of allotment.
Back
to News Review index page
Datamatics IPO: Price band at
Rs 101-110
Mumbai: Datamatics Technologies has announced a
price band of Rs 101-110 for its initial public offering
(IPO), of 1.03 crores equity shares of Rs 5 each. The
IPO remains open from April 12-19. The IPO is through
a 100 per cent book building process. Datamatics will
list the shares on the Bombay Stock Exchange and the National
Stock Exchange. The proceeds of the IPO will be used for
the company's existing business requirements and strategic
initiatives and acquisitions.
Back
to News Review index page
|